GT BIOPHARMA INC

CUSIP: 36254L209 Class: COMMON

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 95,239 Value ($000) $24 Avg Close — Range —
Q3 2023
Shares 95,239 Value ($000) $23 Avg Close — Range —
Q2 2023
Shares 95,239 Value ($000) $30 Avg Close — Range —
Q1 2023
Shares 95,239 Value ($000) $52 Avg Close — Range —
Q4 2022
Shares 95,239 Value ($000) $84 Avg Close — Range —
Q3 2022
Shares 95,239 Value ($000) $167 Avg Close — Range —
Q2 2022
Shares 98,664 Value ($000) $294 Avg Close — Range —
Q1 2022
Shares 142,048 Value ($000) $409 Avg Close — Range —
Q4 2021
Shares 145,123 Value ($000) $441 Avg Close — Range —
Q3 2021
Shares 137,156 Value ($000) $925 Avg Close — Range —
Q2 2021
Shares 58,711 Value ($000) $910 Avg Close — Range —